TG THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expenses, Other
TG THERAPEUTICS, INC. (TGTX) reported Increase (Decrease) in Prepaid Expenses, Other of $2.23 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2019-11-12
- TG THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2019-09-30 was $1.56M.
- TG THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2019-06-30 was $3.12M.
- TG THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2019-03-31 was -$2.45M, a 455.14% decline year-over-year.
- TG THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2018-09-30 was -$2.21M.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month |
|---|---|---|---|
| 2019-09-30 | $1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $4.68M derived: sum of 2 quarters · filed 2019-11-12 | $2.23M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $3.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $663.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | -$2.45M 10-Q · filed 2019-05-10 | ||
| 2018-09-30 | -$2.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$4.11M derived: sum of 2 quarters · filed 2019-11-12 | -$3.42M 10-Q · filed 2019-11-12 |
| 2018-06-30 | -$1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$1.21M 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $691.00K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |